Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye
Authors:
- Yeşim YıldızYYYeşim Yıldız
- Burcu Öztürk ŞahinBŞBurcu Öztürk Şahin
- Mert Can TaşdemirMTMert Can Taşdemir
- Şerife DemirŞDŞerife Demir
- Beyza ÇiftciBÇBeyza Çiftci
- Nurdan KöktürkNKNurdan Köktürk
- Tansu Ulukavuk ÇiftçiTÇTansu Ulukavuk Çiftçi
- Ahmet Selim YurdakulAYAhmet Selim Yurdakul
- Nilgün Yılmaz DemirciNDNilgün Yılmaz Demirci
- Müge AydoğduMAMüge Aydoğdu
- Murat DizbayMDMurat Dizbay
- İpek Kıvılcım OğuzülgenIOİpek Kıvılcım Oğuzülgen
Open Access
- 22 September 2023
- journal article
- research article
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 261-272
Abstract
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.Keywords
This publication has 24 references indexed in Scilit:
- Assessment of olfactory and gustatory functions in COVID-19 patientsTURKISH JOURNAL OF MEDICAL SCIENCES, 2021
- Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Immunity, 2021
- COVID-19 long haulersNature Biotechnology, 2021
- Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent SymptomsFrontiers in Microbiology, 2021
- Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global PandemicClinical Infectious Diseases, 2021
- Sequelae in Adults at 6 Months After COVID-19 InfectionJAMA Network Open, 2021
- Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Cell, 2020
- Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infectionPLOS ONE, 2020
- Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluationJournal of Medical Virology, 2020
- The COVID-19 Cytokine Storm; What We Know So FarFrontiers in Immunology, 2020